Please use this identifier to cite or link to this item: http://scholarbank.nus.edu.sg/handle/10635/33363
Title: Virtual Screening of Multi-Target Agents by Combinatorial Machine Learning Methods
Authors: SHI ZHE
Keywords: virtual screening, multi-target, machine learning methods
Issue Date: 13-Sep-2011
Source: SHI ZHE (2011-09-13). Virtual Screening of Multi-Target Agents by Combinatorial Machine Learning Methods. ScholarBank@NUS Repository.
Abstract: Multi-target drugs have greatly attracted the attention and interest in drug discovery. As a joint effort, the Kinetics database of biomolecular interactions and the Therapeutic targets database were upgraded. They can offer informative data in multi-target drug discovery. I explored combinatorial support vector machines (COMBI-SVM) tool for virtual screening of multi-target agents. After the preliminarily tests of COMBI-SVMs for 4 dual-kinase inhibitors pairs (EGFR-Src, EGFR-FGFR, VEGFR-Lck, Src-Lck), I applied the COMBI-SVMs to the identification of dual-target antidepressant agents of 7 target combinations (serotonin transporter paired with noradrenaline transporter, H3 receptor, 5-HT1A receptor, 5-HT1B receptor, 5-HT2C receptor, Melanocortin 4 receptor and Neurokinin 1 receptor respectively). COMBI-SVMs were compared to other VS methods in varies testing sets (e.g. MDDR and PubChem databases). They showed comparable dual-inhibitor yields, moderate to good target selectivity in misidentifying individual-target inhibitors of the same target pair and inhibitors of the other target pairs as dual-inhibitors, low dual-inhibitor false-hit rates in screening large databases MDDR and PubChem.
URI: http://scholarbank.nus.edu.sg/handle/10635/33363
Appears in Collections:Ph.D Theses (Open)

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
SHI_Zhe_Thesis_2011.pdf2.77 MBAdobe PDF

OPEN

NoneView/Download

Page view(s)

228
checked on Dec 11, 2017

Download(s)

461
checked on Dec 11, 2017

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.